SCHEMBL7537049

SCHEMBL7537049

CN1CCC(C(C(=O)NO)N(C)S(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 13/20 0.50
MMP1 P03956 8/20 0.50
MMP13 P45452 8/20 0.50
ADAM17 P78536 6/20 0.50
ADAMTS7 Q9UKP4 1/20 0.49
ADAMTS5 Q9UNA0 1/20 0.49
HTR2A P28223 3/20 0.48
HTR2C P28335 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
MMP2 P08253 8/20 0.42
MMP8 P22894 3/20 0.42
MMP3 P08254 2/20 0.42
MMP7 P09237 1/20 0.42
DUT P33316 1/20 0.42
MMP12 P39900 1/20 0.42
MMP14 P50281 1/20 0.42
ALDH1A1 P00352 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7537041 1.00 MMP9 (0.50) MMP9MMP1MMP13ADAM17ADAMTS7
SCHEMBL7531012 0.90 ADAMTS7 (0.51) MMP9MMP1MMP13ADAM17ADAMTS7
SCHEMBL7531009 0.90 ADAMTS7 (0.51) MMP9MMP1MMP13ADAM17ADAMTS7
SCHEMBL7535443 0.89 MMP1 (0.46) MMP9MMP1MMP13ADAM17ADAMTS7
SCHEMBL7535439 0.89 MMP1 (0.46) MMP9MMP1MMP13ADAM17ADAMTS7
SCHEMBL7534409 0.87 MMP1 (0.47) MMP9MMP1MMP13ADAM17ADAMTS7
SCHEMBL7534411 0.87 MMP1 (0.47) MMP9MMP1MMP13ADAM17ADAMTS7
SCHEMBL7536591 0.80 MMP13 (0.51) MMP9MMP1MMP13ADAM17ADAMTS7
SCHEMBL7536587 0.80 MMP13 (0.51) MMP9MMP1MMP13ADAM17ADAMTS7
SCHEMBL7541547 0.79 MMP9 (0.45) MMP9MMP1MMP13ADAM17HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-H1992-H1 INHIBITION OF METALLOPROTEINASES AND TUMOR NECROSIS FACTOR CONVERTASE WHICH DEGRADE PROTEIN COMPONENTS OF EXTRACELLULAR MATRIX AGOURON PHARMACEUTICALS, INC. 2001-09-04 US claimed
WO-1998050348-A1 METALLOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES AGOURON PHARMACEUTICALS, INC. (US) 1998-11-12 WO claimed
WO-1998050348-A1 METALLOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES AGOURON PHARMACEUTICALS, INC. (US) 1998-11-12 WO disclosed